Press Releases April 16, 2026 08:00 AM

Westwood Holdings Group, Inc. to Host First Quarter 2026 Conference Call/Webcast

Westwood Holdings Group to Announce First Quarter 2026 Earnings and Host Conference Call

By Nina Shah
Share
Twitter Reddit Facebook LinkedIn
WHG

Westwood Holdings Group, Inc. announced that it will release its first quarter 2026 earnings on April 30, 2026, after the close of the New York Stock Exchange. The company will simultaneously host a live audio webcast and conference call to discuss the results and provide insights into its performance. Westwood is a boutique asset management firm offering actively-managed investment strategies, wealth services, and trust solutions to a variety of clients.

Westwood Holdings Group, Inc. to Host First Quarter 2026 Conference Call/Webcast
WHG
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Westwood Holdings Group plans to release Q1 2026 earnings on April 30, 2026, followed by a webcast and conference call.
  • The company is a boutique asset management firm offering diverse, actively-managed and outcome-oriented investment strategies to institutional, intermediary, and private wealth clients.
  • Westwood emphasizes its client-first approach, diversity, and commitment to delivering bespoke investment strategies with exceptional client service.

DALLAS, April 16, 2026 (GLOBE NEWSWIRE) -- Westwood Holdings Group, Inc. (NYSE:WHG) will release its first quarter 2026 earnings after the close of the New York Stock Exchange on Thursday, April 30, 2026. Following the release, the Company will host a live audio webcast and conference call at 4:30 pm Eastern Time (3:30 pm Central Time).

To join the conference call, please register here: https://register-conf.media-server.com/register/BIdb34b349c6fa4805b8602ecfcfffcf2e. After registering, you will be provided with a dial-in number containing a personalized PIN.

To view the webcast, please register here: https://edge.media-server.com/mmc/p/kxpx4oyr. Once registered, an email will be sent with important details for this conference call, as well as a unique Registrant ID.

Date: April 30, 2026

Time: 4:30 PM ET

Listen via Internet: westwoodgroup.com/investor-relations/events-webcasts

Westwood Holdings Group (NYSE: WHG) is a boutique asset management firm that offers a diverse array of actively-managed and outcome-oriented investment strategies, along with white-glove trust and wealth services, to institutional, intermediary and private wealth clients. For over 40 years, Westwood’s client-first approach has fostered strong, long-term client relationships due to our unwavering commitment to delivering bespoke investment strategies with a vehicle-optimized approach, exceptional counsel and unparalleled client service. Our flexible and agile approach to investing allows us to adapt to constantly changing markets, while continually seeking innovative strategies that meet our investors’ short and long-term needs.

Our team at Westwood comes from varied backgrounds and life experiences, which reflects our origins as a woman-founded firm. We are committed to incorporating diverse insights and knowledge into all aspects of our services and solutions. Our culture and approach to our business reflect our core values - integrity, reliability, responsiveness, adaptability, teamwork and driving results - and underpin our constant pursuit of excellence.

For more information on Westwood, please visit westwoodgroup.com.

(WHG-G)


Risks

  • Earnings performance may be impacted by volatile financial markets affecting asset management revenue and client investments.
  • As a boutique asset manager, Westwood's results may be sensitive to shifts in client demand and flows in institutional and wealth management sectors.
  • Uncertainties around broader economic conditions and market volatility could influence investment outcomes and growth prospects for Westwood.

More from Press Releases

Agios Showcases RISE UP Phase 3 Results at EHA 2026 Plenary Session Reinforcing Strong Anti-Hemolytic Profile of Mitapivat in Sickle Cell Disease Jun 13, 2026 Rhythm Pharmaceuticals Presents Positive Interim Six-month Data from Phase 2 Trial of Setmelanotide in Patients with Prader-Willi Syndrome (PWS) at ENDO 2026 Jun 13, 2026 Intellia Therapeutics Reports Additional Positive Phase 3 Results for Lonvoguran Ziclumeran (lonvo-z) in Patients with Hereditary Angioedema Jun 13, 2026 Arcadia Biosciences (RKDA) Announces Closing of $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules Jun 12, 2026 Belite Bio Completes Rolling Submission of New Drug Application to U.S. Food and Drug Administration for Tinlarebant for the Treatment of Stargardt Disease Type 1 Jun 12, 2026